LICENSE AGREEMENTLicense Agreement • October 31st, 2016 • Oxis International Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 31st, 2016 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the "Agreement"), effective as of March 10, 2015 (the "Effective Date"), is made by and between Oxis Biotech, Inc., a Delaware corporation, having a place of business at 1407 North Beverly Drive, Beverly Hills, CA 90210 ("OXIS") and MultiCell Immunotherapeutics, Inc., a Delaware corporation, having a place of business at 68 Cumberland Street, Suite 301, Woonsocket, RI 02895 (hereinafter "MCIT").
EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License Agreement • October 31st, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 31st, 2016 Company Industry JurisdictionTHIS EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made by and between Regents of the University of Minnesota, a constitutional corporation under the laws of the state of Minnesota, having a place of business at 200 Oak Street, SE, Suite 280, Minneapolis, Minnesota 55455 (the "University"), and the Licensee identified below. The University and the Licensee agree that:
LICENSE AGREEMENTLicense Agreement • October 31st, 2016 • Oxis International Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 31st, 2016 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the "Agreement") dated as of December 31, 2014 (the "Effective Date"), is entered into between ID4 Pharma, LLC ("ID4"), a having a place of business at 1654 Settlers Drive, Sewickley, PA 15143, and Oxis Biotech, Inc., a Delaware corporation ("Company"), having a place of business at 1402 North Beverly Drive, Beverly Hills, CA 90210 .
LICENSE AGREEMENTLicense Agreement • October 31st, 2016 • Oxis International Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 31st, 2016 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this "Agreement") dated as of September 3, 2015 (the "Effective Date"), is entered into between Daniel A. Vallera, an individual having a place of residence at ____________________________________ , Jeffrey Lion, an individual having a place of residence at ____________________________________ (collectively hereinafter "Licensor"), and Oxis Biotech, Inc., a Delaware corporation ("Company" or "Oxis"), having a place of business at 1402 North Beverly Drive, Beverly Hills, CA 90210 .